CD8A and metabolic dysfunction-associated steatohepatitis: Further investigations uncovered that NASH impairs the mobility and mitochondrial fitness of CD8+ T cells by inducing mitochondrial depolarization and mass reduction, while also decreasing glycolysis in intratumoral CD8+ T cells.